Chinese COVID-19 vaccines

Statistics report about Chinese COVID-19 vaccines

Chinese COVID-19 vaccines

This report presents the most important information about Chinese COVID-19 vaccines. Starting with the production figures for Chinese COVID-19 vaccines, it reveals the substantial growth of the sector with key financial indicators of three major Chinese vaccine developers. The report also covers the domestic adoption, international trade, and donations of Chinese COVID-19 vaccines, as well as the opinions of the general public.

Table of contents

Overview

6
  • Basic Statistic COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country
  • Basic Statistic COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023
  • Basic Statistic COVID-19 vaccination doses in China 2020-2022
  • Premium Statistic Number of COVID-19 vaccine doses produced in China 2021-2022
  • Premium Statistic International deliveries of Chinese COVID-19 vaccines 2020-2022, by region
  • Premium Statistic Public interests over adult vaccines in China 2022, by type of vaccines

Sinovac

6
  • Premium Statistic Number of COVID-19 vaccine doses produced by Sinovac 2021-2022
  • Premium Statistic Share of Sinovac's COVID-19 vaccine deliveries by country income group 2021
  • Premium Statistic Annual revenue of Sinovac Biotech Ltd. 2016-2022
  • Premium Statistic Sinovac Biotech Ltd. annual gross profit 2016-2022
  • Premium Statistic Sinovac Biotech Ltd. annual net income 2016-2022
  • Premium Statistic Research and development costs of Sinovac Biotech Ltd. 2016-2022

Sinopharm and CanSino

6
  • Premium Statistic Number of COVID-19 vaccine doses produced by Sinopharm BIBP 2021-2022
  • Premium Statistic Share of Sinopharm's COVID-19 vaccine deliveries by country income group 2021
  • Premium Statistic Revenue of Sinopharm 2011-2022, by category
  • Premium Statistic Annual revenue of CanSino Biologics Inc. 2017-2021
  • Premium Statistic Revenue distribution of CanSino Biologics Inc. 2021, by market
  • Premium Statistic Annual operating income of CanSino Biologics Inc. 2017-2021

Domestic adoption

5
  • Basic Statistic New COVID-19 vaccine doses administered daily in China 2021-2022
  • Premium Statistic COVID-19 vaccination in China 2021-2022, by status
  • Premium Statistic COVID-19 vaccination rate in China 2021-2022, by status
  • Basic Statistic COVID-19 vaccine booster doses in China 2021-2022
  • Premium Statistic COVID-19 vaccination rate among the elderly population in China 2022, by age group

Exports

5
  • Premium Statistic Number of Chinese COVID-19 vaccines sold overseas 2020-2022, by region
  • Premium Statistic International donations of Chinese COVID-19 vaccines 2020-2022, by region
  • Basic Statistic Confirmed doses of COVID-19 vaccines in Chile 2022, by producer
  • Premium Statistic Global attitudes on COVID-19 vaccines developed in China 2020
  • Premium Statistic Most trusted COVID-19 vaccine brands ASEAN 2021

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)